162 related articles for article (PubMed ID: 33894716)
1. The impact of pretransplant hepatic encephalopathy, model for end-stage liver disease (MELD) scale on long-term survival following deceased donor liver transplantation: a retrospective study.
Yoon JU; Yoo YM; Byeon GJ; Kim HJ; Choi EJ; Park S; Kim HY
Ann Palliat Med; 2021 May; 10(5):5171-5180. PubMed ID: 33894716
[TBL] [Abstract][Full Text] [Related]
2. Survival benefit of living-donor liver transplantation in patients with a model for end-stage liver disease over 30 in a region with severe organ shortage: a retrospective cohort study.
Yim SH; Kim DG; Kang M; Koh HH; Choi MC; Min EK; Lee JG; Kim MS; Joo DJ
Int J Surg; 2023 Nov; 109(11):3459-3466. PubMed ID: 37565633
[TBL] [Abstract][Full Text] [Related]
3. Living donor liver transplant versus cadaveric liver transplant survival in relation to model for end-stage liver disease score.
Al Sebayel M; Abaalkhail F; Hashim A; Al Bahili H; Alabbad S; Shoukdy M; Elsiesy H
Transplant Proc; 2015 May; 47(4):1211-3. PubMed ID: 26036556
[TBL] [Abstract][Full Text] [Related]
4. Hepatic encephalopathy is associated with significantly increased mortality among patients awaiting liver transplantation.
Wong RJ; Gish RG; Ahmed A
Liver Transpl; 2014 Dec; 20(12):1454-61. PubMed ID: 25155379
[TBL] [Abstract][Full Text] [Related]
5. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
[TBL] [Abstract][Full Text] [Related]
6. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.
Gadiparthi C; Cholankeril G; Yoo ER; Hu M; Wong RJ; Ahmed A
Dig Dis Sci; 2018 Jun; 63(6):1647-1653. PubMed ID: 29611079
[TBL] [Abstract][Full Text] [Related]
7. Pretransplant mortality predictors in living and deceased donor liver transplantation.
Jo YY; Choi YS; Joo DJ; Yoo YC; Nam SG; Koh SO
J Chin Med Assoc; 2014 Jan; 77(1):16-20. PubMed ID: 24168841
[TBL] [Abstract][Full Text] [Related]
8. The impact of pretransplant hepatic encephalopathy on survival following liver transplantation.
Wong RJ; Aguilar M; Gish RG; Cheung R; Ahmed A
Liver Transpl; 2015 Jul; 21(7):873-80. PubMed ID: 25902933
[TBL] [Abstract][Full Text] [Related]
9. Pretransplant severe hepatic encephalopathy, peritransplant sodium and post-liver transplantation morbidity and mortality.
Brandman D; Biggins SW; Hameed B; Roberts JP; Terrault NA
Liver Int; 2012 Jan; 32(1):158-64. PubMed ID: 22098119
[TBL] [Abstract][Full Text] [Related]
10. Hepatic encephalopathy expands the predictivity of model for end-stage liver disease in liver transplant setting: Evidence by means of 2 independent cohorts.
Lucidi C; Ginanni Corradini S; Abraldes JG; Merli M; Tandon P; Ferri F; Parlati L; Lattanzi B; Poli E; Di Gregorio V; Farcomeni A; Riggio O
Liver Transpl; 2016 Oct; 22(10):1333-42. PubMed ID: 27434824
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of hepatitis C recurrence and fibrosis progression between deceased-donor and living-donor liver transplantation: 8-year longitudinal follow-up.
Jain A; Singhal A; Kashyap R; Safadjou S; Ryan CK; Orloff MS
Transplantation; 2011 Aug; 92(4):453-60. PubMed ID: 21799468
[TBL] [Abstract][Full Text] [Related]
12. Impact of Model for End-stage Liver Disease Score-based Allocation System in Korea: A Nationwide Study.
Lee J; Kim DG; Lee JY; Lee JG; Joo DJ; Kim SI; Kim MS
Transplantation; 2019 Dec; 103(12):2515-2522. PubMed ID: 30985735
[TBL] [Abstract][Full Text] [Related]
13. Comparable Short- and Long-term Outcomes in Living Donor and Deceased Donor Liver Transplantations for Patients With Model for End-stage Liver Disease Scores ≥35 in a Hepatitis-B Endemic Area.
Chok KS; Fung JY; Chan AC; Dai WC; Sharr WW; Cheung TT; Chan SC; Lo CM
Ann Surg; 2017 Jan; 265(1):173-177. PubMed ID: 28009743
[TBL] [Abstract][Full Text] [Related]
14. Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation.
Terrault NA; Shiffman ML; Lok AS; Saab S; Tong L; Brown RS; Everson GT; Reddy KR; Fair JH; Kulik LM; Pruett TL; Seeff LB;
Liver Transpl; 2007 Jan; 13(1):122-9. PubMed ID: 17192908
[TBL] [Abstract][Full Text] [Related]
15. Clinical analysis of emergency liver transplantation: the role of living donor liver transplantation.
Kim SJ; Yoon YC; Yoo YK; Park JH; Kim DG
Clin Transplant; 2012; 26(6):833-41. PubMed ID: 22594714
[TBL] [Abstract][Full Text] [Related]
16. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
Kwong AJ; Lai JC; Dodge JL; Roberts JP
Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
[TBL] [Abstract][Full Text] [Related]
17. Long Term Outcomes of Liver Transplantation For Patients With Autoimmune Hepatitis.
Alswat K; Soliman E; Salih I; Bashmail A; Letierce A; Benmousa A; Alghamdi S; Bzeizi KI; Alqahtani SA; Shawkat M; Broering DC; Al-Hamoudi WK
Transplant Proc; 2021 Sep; 53(7):2339-2345. PubMed ID: 34474912
[TBL] [Abstract][Full Text] [Related]
18. Impact of preoperative serum sodium concentration in living donor liver transplantation.
Fukuhara T; Ikegami T; Morita K; Umeda K; Ueda S; Nagata S; Sugimachi K; Gion T; Yoshizumi T; Soejima Y; Taketomi A; Maehara Y
J Gastroenterol Hepatol; 2010 May; 25(5):978-84. PubMed ID: 20546453
[TBL] [Abstract][Full Text] [Related]
19. High MELD score does not adversely affect outcome of living donor liver transplantation: Experience in 1000 recipients.
Yadav SK; Saraf N; Saigal S; Choudhary NS; Goja S; Rastogi A; Bhangui P; Soin AS
Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28497523
[TBL] [Abstract][Full Text] [Related]
20. A multicenter study of 30 days complications after deceased donor liver transplantation in the model for end-stage liver disease score era.
Parikh A; Washburn KW; Matsuoka L; Pandit U; Kim JE; Almeda J; Mora-Esteves C; Halff G; Genyk Y; Holland B; Wilson DJ; Sher L; Koneru B
Liver Transpl; 2015 Sep; 21(9):1160-8. PubMed ID: 25991395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]